|
|
|
|
Vol. 62, Issue 3, 756-761, September 2002
Departments of Neurosurgery (Y.K., N.H.) and Pharmacology (Y.K., T.M.), Kyoto University Faculty of Medicine, Kyoto, Japan
| |
Abstract |
|---|
|
|
|---|
We recently demonstrated that endothelin-1 (ET-1) activates
two types of Ca2+-permeable nonselective cation channel
(designated NSCC-1 and NSCC-2) and a store-operated Ca2+
channel (SOCC) in Chinese hamster ovary cells expressing
endothelinA receptor (CHO-ETAR). In addition,
these channels can be discriminated using Ca2+ channel
blockers
(R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid mesylate (LOE 908) and
1-(
-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl)-1H-imidazole (SK&F 96365). LOE 908 is a blocker of NSCC-1 and NSCC-2, whereas SK&F
96365 is a blocker of SOCC and NSCC-2. In this study, we investigated
the effects of phosphoinositide 3-kinase (PI3K) on the ET-1-induced
activation of these channels and mitogenesis in CHO-ETAR
using wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY 294002), inhibitors of phosphoinositide 3-kinase (PI3K).
ET-1-induced Ca2+ influx was partially inhibited in
CHO-ETAR pretreated with wortmannin or LY 294002. In
contrast, addition of wortmannin or LY 294002 after stimulation with
ET-1 did not suppress Ca2+ influx. The Ca2+
channels activated by ET-1 in wortmannin or LY 294002-treated CHO-ETAR were sensitive to LOE 908 and resistant to SK&F
96365. Wortmannin also partially inhibited ET-1-induced mitogenesis. LOE 908, but not SK&F 96365, abolished the wortmannin-resistant part of
mitogenesis. The IC50 values (~30 nM) of wortmannin for the ET-1-induced Ca2+ influx and mitogenesis were similar
to those for the ET-1-induced PI3K activation. In conclusion, NSCC-2
and SOCC are stimulated by ET-1 via PI3K-dependent cascade, whereas
NSCC-1 is stimulated via PI3K-independent cascade. Moreover, PI3K seems
to be required for the activation of the Ca2+ entry, but
not for its maintenance. In addition, PI3K is involved in the
ET-1-induced mitogenesis that depends on the extracellular Ca2+ influx through SOCC and NSCC-2.
| |
Introduction |
|---|
|
|
|---|
Endothelin-1
(ET-1) was discovered as a potent vasoconstricting peptide secreted
from endothelial cells (Yanagisawa et al., 1988
). It is generally
accepted that ET-1 may play a role in the pathogenesis of certain
clinical conditions, such as hyperlipoproteinemia, atherosclerosis,
stroke, cerebral vasospasm, and tumor growth (Lerman et al., 1991
; Haak
et al., 1994
). Moreover, recent reports showed that the extracellular
Ca2+ influx is required for ET-1-induced
vascular contraction and mitogenesis (Zhang et al., 1999
; Kawanabe et
al., 2002a
). These results indicate that if the activation pathways of
Ca2+ channels involved in the extracellular
Ca2+ influx caused by ET-1 are revealed, blockade
of these pathways may become a new treatment for ET-1-induced clinical
conditions described above. We recently demonstrated that the sustained
increase in intracellular free Ca2+ concentration
([Ca2+]i) caused by ET-1
results from Ca2+ entry through three types of
VICC in CHO cells stably expressing human
endothelinA receptors
(CHO-ETAR), two types of
Ca2+-permeable nonselective cation channel
(designated NSCC-1 and NSCC-2), and a store-operated
Ca2+ channel (SOCC) (Kawanabe et al., 2001
).
Importantly, these channels can be distinguished in terms of the
sensitivity to Ca2+ channel blockers SK&F 96365 and LOE 908. NSCC-1 is sensitive to LOE 908 and resistant to SK&F
96365; NSCC-2 is sensitive to both LOE 908 and SK&F 96365; and SOCC is
resistant to LOE 908 but sensitive to SK&F 96365 (Kawanabe et al.,
2001
). VICCs activated by ET-1 in CHO-ETAR seem
to be pharmacologically similar to those in vascular smooth muscle
cells, which predominantly express ETARs (Kawanabe et al., 2002a
). Therefore, our findings on CHO cells may give
some insights into the functional roles of ETARs
related to ET-1-induced Ca2+ channel activation
on vascular smooth muscle cells.
The types of G
protein involved in activation
of NSCC-1, NSCC-2, and SOCC are different in
CHO-ETAR. NSCC-1 is activated via a
G12-dependent pathway, NSCC-2 is activated via
both a Gq/phospholipase C (PLC)- and a
G12-dependent pathway, and SOCC is activated via a Gq/PLC-dependent pathway (Kawanabe et al.,
2002c
). However, less is known about intracellular signaling pathways
regulate the activation of these Ca2+ channels.
Previous reports demonstrate that phosphoinositide 3-kinase (PI3K)
plays important roles for stimulation of L-type voltage-dependent
Ca2+ channels by angiotensin (Seki et al., 1999
;
Viard et al., 1999
) and T-cell Ca2+ signaling via
phosphatidylinositol 3,4,5-triphosphate-sensitive Ca2+ entry pathway (Hsu et al., 2000
). ET-1
activates PI3K in CHO-ETAR from the data using
the PI3K inhibitor wortmannin (Sugawara et al., 1996
). Therefore, at
first, we examined whether and which VICCs are activated by ET-1 in
CHO-ETAR via PI3K-dependent pathway.
ET-1 induces mitogenic response in CHO-ETAR
(Sugawara et al., 1996
). However, it remains unclear whether
Ca2+ influx is essential for ET-1-induced
mitogenesis of CHO-ETAR, and it is equally
unclear what types of Ca2+ channels are involved
in mitogenesis in CHO-ETAR. We attempted to
pharmacologically characterize the Ca2+ channels
involved in ET-1-induced mitogenesis in CHO-ETAR
using SK&F 96365 and LOE 908. We also investigated the effects of PI3K on the ET-1-induced mitogenesis that depends on extracellular Ca2+ influx.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture.
Stable expression of
ETARs in CHO cells was accomplished as
described previously (Kawanabe et al., 2001
).
CHO-ETAR were routinely maintained in Ham's F12
medium supplemented with 10% fetal calf serum under a humidified
atmosphere of 5% CO2/95% air.
Monitoring of [Ca2+]i in
CHO-ETAR.
The
[Ca2+]i was monitored
using the fluorescent probe fluo-3 as described previously (Kawanabe et
al., 2001
).
MTT assay.
Cells were seeded into 96-well plates at 5 × 103 cells/well for the assay using
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT).
They were incubated overnight in Ham's F12 medium supplemented with
10% fetal calf serum at 37°C. The cells were deprived of serum for
24 h, washed with phosphate-buffered saline, and incubated with
ET-1 for a further 48 h in serum-free Ham's F12 medium with or
without Ca2+ channel blockers. MTT assay was
performed as described previously (Kawanabe et al., 2002a
).
Drugs. LOE 908 was kindly provided by Boehringer Ingelheim K.G. (Ingelheim, Germany). Other chemicals were commercially obtained from the following sources: ET-1 from Peptide Institute (Osaka, Japan); SK&F 96365 from Biomol (Plymouth Meeting, PA); fluo-3/acetoxymethyl ester from Dojindo Laboratories (Kumamoto, Japan); wortmannin from Wako (Osaka, Japan); and MTT and LY 294002 from Sigma-Aldrich (St. Louis, MO)
Statistical analysis. All results were expressed as mean ± S.E.M.
| |
Results |
|---|
|
|
|---|
Effects of Wortmannin on the ET-1-Induced Increase in
[Ca2+]i in CHO-ETAR.
ET-1 at
10 nM induced a biphasic increase in
[Ca2+]i consisting of an
initial transient peak and a subsequent sustained increase in both
CHO-ETAR and CHO-ETAR
preincubated with wortmannin (Fig. 1, A
and B). The magnitude of the transient peak and that of the sustained
increase in [Ca2+]i
depended on the concentration of ET-1 (Fig. 1, C and D). In experiments
performed on cells incubated in a bath in which the extracellular
Ca2+ had been removed, the transient peak was not
affected on treatment with 10 nM ET-1, but the sustained increase was
abolished (data not shown). The EC50 values (~1
nM) and the maximal effective concentration (10 nM) of ET-1 for
transient increase in
[Ca2+]i in
CHO-ETAR preincubated with 1 µM wortmannin was
similar to those in CHO-ETAR (Fig. 1C). On the
other hand, the magnitude of sustained increase in
[Ca2+]i caused by 10 nM
ET-1 in CHO-ETAR preincubated with wortmannin was
~20% of that in CHO-ETAR (Fig. 1D). In
contrast, addition of wortmannin after stimulation with ET-1 did not
affect the sustained increase in
[Ca2+]i (Fig. 1A).
|
1 µM (Fig. 2,
A and C). In contrast, wortmannin up to 1 µM failed to suppress
ET-1-induced transient increase in
[Ca2+]i (Fig. 2, A and
B).
|
Effects of LY 294002 on the ET-1-Induced Increase in
[Ca2+]i in CHO-ETAR.
We also
used LY 294002 to evaluate the effects of PI3K on ET-1-induced
extracellular Ca2+ influx. LY 294002 at 50 µM
inhibited PI3K activation completely in CHO cells (Kurashima et al.,
1998
). The magnitudes of ET-1-induced transient increase in
[Ca2+]i in
CHO-ETAR preincubated with 50 µM LY 294002 were
similar to those in CHO-ETAR (Fig.
3, B and C). On the other hand, 50 µM
LY 294002 inhibited ET-1-induced sustained increase in
[Ca2+]i, and ~80%
inhibition was obtained (Fig. 3, B and D). Moreover, addition of LY
294002 after stimulation with ET-1 did not affect the sustained
increase in [Ca2+]i (Fig.
3A).
|
Effects of SK&F 96365 and LOE 908 on ET-1-Induced Sustained
Increase in [Ca2+]i in CHO-ETAR
Preincubated with Wortmannin.
The ET-1-induced sustained increase
in [Ca2+]i in
CHO-ETAR preincubated with 1 µM wortmannin was
inhibited by LOE 908 in a concentration-dependent manner, and complete
inhibition was observed at concentrations
10 µM (Fig.
4). In contrast, SK&F 96365 up to 10 µM
failed to inhibit ET-1-induced sustained increase in
[Ca2+]i in
CHO-ETAR preincubated with 1 µM wortmannin
(Fig. 4). These results suggest that NSCC-1 is activated by ET-1 via
wortmannin-independent pathway, whereas NSCC-2 and SOCC are activated
via wortmannin-dependent pathway. In CHO-ETAR
preincubated with 50 µM LY 294002, ET-1-induced sustained increase
in [Ca2+]i was also
sensitive to LOE 908 and resistant to SK&F 96365 (data not shown).
|
Effects of Wortmannin on ET-1-Induced Sustained Increase in
[Ca2+]i in CHO Cells Expressing
Unpalmitoylated Mutant ETAR (SerETAR).
To
assess the effects of wortmannin on the activation of NSCC-1, we used
CHO-SerETAR. SerETAR is
unpalmitoylated because of substitution of all the cysteine residues to
serine
(Cys383Cys385-388
Ser383Ser385-388)
and activates only NSCC-1 (Kawanabe et al., 2002b
,c
). Wortmannin at 1 µM did not affect ET-1-induced sustained increase in
[Ca2+]i in
CHO-SerETAR (Fig.
5). LOE 908 at 10 µM inhibited
ET-1-induced sustained increase in
[Ca2+]i completely in
wortmannin-treated CHO-SerETAR (Fig. 5). On the other hand, SK&F 96365 at 10 µM failed to inhibit ET-1-induced sustained increase in
[Ca2+]i in these cells
(Fig. 5).
|
Effects of ET-1 on Mitogenic Response in CHO-ETAR.
After stimulation with ET-1, the number of viable cells as estimated by
the MTT assay increased with time up to 48 h in
CHO-ETAR (Fig. 6A).
Therefore, in subsequent experiments, the stimulation time was set at
48 h.
|
10 nM (Fig. 6B). In the following experiments, ET-1
was added to the incubation media at a final concentration of 10 nM to
analyze the role of Ca2+ channels in mitogenesis
in CHO-ETAR.
Effects of SK&F 96365 and LOE 908 on ET-1-induced mitogenesis in
CHO-ETAR.
Using SK&F 96365 and LOE 908, we attempted
to determine the effects of Ca2+ influx through
VICCs on the ET-1-induced mitogenic response in CHO-ETAR. SK&F 96365 inhibited ET-1-induced
mitogenesis in a concentration-dependent manner with an
IC50 value of ~3 µM. Maximal inhibition was
observed at concentrations
10 µM (Fig.
7A). The extent of maximal inhibition was
~80% (Fig. 7B). Similarly, the IC50 values of
LOE 908 for inhibition of ET-1-induced mitogenesis were ~3 µM, and
maximal inhibition was observed at concentrations
10 µM (Fig. 7A).
The extent of maximal inhibition was ~60% (Fig. 7B). Notably, the ET-1-induced mitogenesis was abolished by combined treatment with the
maximally effective concentration (10 µM) of LOE 908 and SK&F 96365 (Fig. 7B). In contrast, neither SK&F 96365 nor LOE 908 had any effects
at concentrations up to 30 µM on the number of cells in the absence
of ET-1 (Fig. 7A).
|
Effects of Wortmannin on ET-1-Induced Mitogenesis in
CHO-ETAR.
Wortmannin inhibited ET-1-induced
mitogenesis in a concentration-dependent manner with an
IC50 value of ~30 nM. Maximal inhibition was
observed at concentrations
1 µM (Fig.
8A). The extent of maximal inhibition was
~80% (Fig. 8B). The wortmannin-resistant part of mitogenesis caused
by ET-1 was abolished by 10 µM LOE 908 (Fig. 8B). In contrast, SK&F
96365 up to 10 µM did not affect the wortmannin-resistant part of
mitogenesis caused by ET-1 (Fig. 8B).
|
| |
Discussion |
|---|
|
|
|---|
It is important to reveal the intracellular activation mechanisms
of VICCs by ET-1. In this study, we focused on the effects of PI3K on
these Ca2+ channels activation caused by ET-1 in
CHO-ETAR because PI3K plays important roles for
stimulation of extracellular Ca2+ influx. Given
that addition of wortmannin or LY 294002 after stimulation with ET-1
did not suppress sustained increase in
[Ca2+]i (Figs. 1A and
3A), wortmannin and LY 294002 seem not to have functions as
Ca2+ channel blockers. Therefore, wortmannin and
LY 294002 may be effectors for intracellular mechanisms involved in
Ca2+ channel activation by ET-1. Moreover, PI3K
seems to be required for the activation of the
Ca2+ entry, but not for its maintenance. The
inhibitory effects of wortmannin on ET-1-induced sustained increase in
[Ca2+]i may be due to its
inhibitory effects on PI3K, judging from the following data: 1)
Wortmannin is generally accepted as a PI3K inhibitor (Ui et al., 1995
).
Moreover, at nanomolar concentrations, wortmannin acts specifically on
PI3K (Yano et al., 1993
). 2) Another PI3K inhibitor, LY 294002, also
inhibited the wortmannin-sensitive part of ET-1-induced sustained
increase in [Ca2+]i. 3)
In CHO-ETAR, the IC50
values (~30 nM) and maximal effective concentration (1 µM) of
wortmannin for ET-1-induced sustained increase in
[Ca2+]i (Fig. 2) were
similar to those for ET-1-induced phosphatidylinositol triphosphate
formation as an index of PI3K activity (Sugawara et al., 1996
).
Because wortmannin partially suppressed ET-1-induced sustained
increase in [Ca2+]i
(Figs. 1 and 2), ET-1 induces extracellular Ca2+
influx through VICCs via both PI3K-dependent and -independent pathways
in CHO-ETAR. Based on the sensitivity to SK&F
96365 and LOE 908, the wortmannin-resistant part of sustained increase
in [Ca2+]i was caused by
Ca2+ influx through NSCC-1 (LOE 908-sensitive and
SK&F 96365-resistant) (Fig. 4). Therefore, Ca2+
influx through NSCC-2 and SOCC are composed of wortmannin sensitive part. These results indicate that PI3K may play important roles for
ET-1-induced activation of NSCC-2 and SOCC. The result that wortmannin
failed to inhibit the activation of NSCC-1 by ET-1 in
CHO-SerETAR (Fig. 5) is consistent with this
indication. Both NSCC-2 and SOCC activations by ET-1 involve
Gq/PLC-dependent cascade and depend on
mobilization of Ca2+ from the intracellular
Ca2+ store in CHO-ETAR
(Kawanabe et al., 2002c
). Moreover, it is generally accepted that
G
is involved in PI3K activation (Clapham and Neer, 1997
; Vanhaesebroeck et al., 1997
). Therefore,
G
as well as G
may
play important roles for NSCC-2 and SOCC activation by ET-1.
ET-1 induces mitogenic response in CHO-ETAR,
judging from results of MTT assay as described previously (Sugawara et
al., 1996
). The inhibitory action of SK&F 96365 or LOE 908 on
ET-1-induced mitogenesis may be mediated by blockade of
Ca2+ entry through VICCs for the following
reasons: the IC50 values of SK&F 96365 and LOE
908 for ET-1-induced mitogenesis and the extent of inhibition of the
response by these blockers (Fig. 7) correlated well with those for the
ET-1-induced [Ca2+]i
response (Kawanabe et al., 2001
), and neither SK&F 96365 nor LOE 908 is
considered to exert cytotoxic effects on quiescent cells, judging from
data from MTT assay (Fig. 7). The ET-1-induced mitogenesis can be
divided into three parts based on its pharmacology. The first part is
sensitive to LOE 908 and resistant to SK&F 96365, the second is
sensitive to both LOE 908 and SK&F 96365, and the third is resistant to
LOE 908 and sensitive to SK&F 96365 (Fig. 7B). The pharmacological
criteria indicate that the first part involves
Ca2+ entry through NSCC-1, the second involves
Ca2+ entry through NSCC-2, and the third involves
Ca2+ entry through SOCC. Furthermore, the
percentage contribution of Ca2+ entry through
NSCC-1, NSCC-2, and SOCC to the mitogenesis is calculated to be 20, 40, and 40%, respectively (Fig. 7B). The inhibitory effects of wortmannin
on ET-1-induced mitogenesis may be mediated by blockade of
Ca2+ entry through NSCC-2 and SOCC for the
following reasons: the IC50 values of wortmannin
for ET-1-induced mitogenesis (Fig. 8A) correlated well with those for
the ET-1-induced [Ca2+]i
response (Fig. 2A), and the wortmannin-resistant part of ET-1-induced mitogenesis was dependent on the extracellular
Ca2+ influx through NSCC-1, based on the
sensitivity to SK&F 96365 and LOE 908 (SK&F 96365-resistant and LOE
908-sensitive) (Fig. 8B). Moreover, these results indicate that PI3K
may be involved in the ET-1-induced mitogenesis by activating
extracellular Ca2+ influx through NSCC-2 and
SOCC.
In conclusion, NSCC-2 and SOCC are stimulated by ET-1 via PI3K-dependent cascade, whereas NSCC-1 is stimulated via PI3K-independent cascade. Moreover, PI3K is involved in the ET-1-induced mitogenesis that depends on the extracellular Ca2+ influx through SOCC and NSCC-2.
| |
Acknowledgments |
|---|
We thank Boehringer Ingelheim K.G. for the kind donation of LOE 908.
| |
Footnotes |
|---|
Received April 5, 2002; Accepted June 18, 2002
This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, by a grant from the Smoking Research Foundation, Japan, and by the Uehara Memorial Foundation Fellowship, Tokyo, Japan.
Address correspondence to: Yoshifumi Kawanabe M.D., Ph.D., Membrane Biology Program, Brigham and Women's Hospital, Harvard Institutes of Medicine, Room 520, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail: ykawanabe{at}rics.bwh.harvard.edu
| |
Abbreviations |
|---|
ET-1, endothelin-1;
[Ca2+]i, intracellular free Ca2+
concentration;
CHO, Chinese hamster ovary;
ETAR, human
endothelinA receptor;
VICC, voltage-independent
Ca2+ channel;
NSCC, nonselective cation channel;
SOCC, store-operated Ca2+ channel;
SK&F 96365, 1-(
-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl)-1H-imidazole;
LOE 908, (R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid
mesylate;
PLC, phospholipase C;
PI3K, phosphoinositide 3-kinase;
MTT, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide;
LY 294002, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one.
| |
References |
|---|
|
|
|---|

subunits.
Annu Rev Pharmacol Toxicol
37:
167-203[CrossRef][Medline].
dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase.
FASEB J
13:
685-694This article has been cited by other articles:
![]() |
D. Chansel, M. Ciroldi, S. Vandermeersch, L. F Jackson, A.-M. Gomez, D. Henrion, D. C. Lee, T. M. Coffman, S. Richard, J.-C. Dussaule, et al. Heparin binding EGF is necessary for vasospastic response to endothelin FASEB J, September 1, 2006; 20(11): 1936 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Levinthal and D. B. DeFranco Transient Phosphatidylinositol 3-Kinase Inhibition Protects Immature Primary Cortical Neurons from Oxidative Toxicity via Suppression of Extracellular Signal-regulated Kinase Activation J. Biol. Chem., March 19, 2004; 279(12): 11206 - 11213. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Characterization of G proteins involved in activation of nonselective cation channels and arachidonic acid release by norepinephrine/{alpha}1A-adrenergic receptors Am J Physiol Cell Physiol, March 1, 2004; 286(3): C596 - C600. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, K. Nozaki, N. Hashimoto, and T. Masaki Characterization of Ca2+ Channels and G Proteins Involved in Arachidonic Acid Release by Endothelin-1/EndothelinA Receptor Mol. Pharmacol., September 1, 2003; 64(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Effects of nonselective cation channels and PI3K on endothelin-1-induced PYK2 tyrosine phosphorylation in C6 glioma cells Am J Physiol Cell Physiol, September 1, 2003; 285(3): C539 - C545. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||